期刊名称：DRUG METABOLISM AND PHARMACOKINETICS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
About DMPK
‘Drug Metabolism and Pharmacokinetics’ is the English journal published by JSSX, which includes manuscripts with high originality in the basic, and applied fields of Pharmacokinetics, Metabolism, Transporter, DDS, Clinical Pharmacology, Analysis, Gene Expression, Pharmacokinetics of xenobiotics including drugs. The journal has a predecessor, ‘Xenobiotic Metabolism and Disposition’, which was published in Japanese since the founding of JSSX. After discussing ways to present our research progresses to researchers outside of Japan, we have decided to publish the journal in English, renewing the title to ‘Drug Metabolism and Pharmacokinetics’ , starting 2002, aiming to create a journal with higher impact. We accept manuscripts in 5 styles, Regular Articles, Notes, Short Communications, SNP Communication and Reviews.
The first characteristic of DMPK is that we accept new, and original manuscripts from basic, and applied studies of the pharmacokinetics of xenobiotics including drugs, and the influence of metabolic enzyme and transporters. Secondly, it is a unique journal that includeｓ research results of pharmacokinetics regarding development of new drugs. Finally, our unique SNP Communications are articles that cannot be seen in other journals, featuring enzymes and transporters of pharmacokinetics, and information of new SNPs which codes the genes that control them. We are known for presenting the newest information of these SNPs and their function analysis.
To appeal these features to the world, and to share our findings, we have started our online journal at J-Stage starting August, 2003. (We have 10,000 accesses a month, with about 4,000 downloads) Our Abstracts are featured on PubMed, and all of our manuscripts can be accessed, anywhere in the world, through PubMed to J-Stage. We have applied to ISI for Impact Factors in 2005, and started our Manuscript submission and referee system of ScholarOne in April, 2006. We hope that these efforts would make participation easier for anyone in all countries of the world.
Instructions to Authors
dmpk_instruction.pdf
Editorial Board
Editorial Board
Editor in chief
Kan Chiba, Prof., Ph.D.
Chiba University, Chiba
Associate Editors
Takashi Izumi, Ph. D.
Drug Metabolism & Pharmacokinetics Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd. |
|
Shogo Ozawa, Ph.D.
Division of Pharmacology,
National Institute of Health Sciences |
| |
|
|
|
|
Prof.Yukio Kato, Ph.D.
Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
|
|
Ryosei Kawai, Ph.D.
Novartis Institutes for BioMedical Research, Inc.
|
| |
|
|
|
|
Prof. Yoshiharu Deguchi, Ph. D.
Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University |
|
Prof.Yukiya Hashimoto, Ph.D.Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama |
| |
|
|
|
|
Prof. Masakiyo Hosokawa, Ph. D.
Laboratory of Drug Metabolism & Biopharmaceutics, Faculty of Pharmaceutical Sciences,Chiba Institute of Science,
|
|
Prof.Hideyuki Yamada, Ph.D.
Graduate School of Pharmaceutical Sciences, Kyushu University |
| |
|
|
|
|
Prof. Jin-ding Huang, PhD
National Cheng Kung University, Tainan |
|
Suk-Jae Chung, Ph.D.
College of Pharmacy, Seoul National University |
Editorial Advisory Board
Young-Nam Cha (Inha University, Incheon, Korea)
Masato Chiba (Banyu Pharmaceutical Co., Ltd., Tsukuba)
Stephen Duffull (University of Otago, New Zealand)
Yukiya Hashimoto (University of Toyama, Toyama)
Kazutaka Higaki (Okayama University, Okayama)
Masakiyo Hosokawa (Chiba Institute of Science, Chiba)
Jin-Ding Huang (National Cheng Kung University, Taiwan)
Ichiro Ieiri (Kyushu University, Fukuoka)
Susumu Imaoka (Kwansei Gakuin University, Hyogo)
Tatsuhiro Ishida (The University of Tokushima, Tokushima)
Kiyomi Ito (Hoshi University, Tokyo)
Tomoo Itoh (Kitasato University, Tokyo)
Kazuhide Iwasaki (Shin Nippon Biomedical Lab., Ltd., Osaka)
Hidefumi Kasai (Bellsystem24, Tokyo)
Motohiro Kato (Chugai Pharmaceutical Co.,Ltd., Shizuoka)
Yukio Kato (Kanazawa University, Kanazawa)
Toshiyuki Kume (Mitsubishi Tanabe Pharma, Chiba)
Hiroyuki Kusuhara (The University of Tokyo, Tokyo)
Edmund J. D. Lee (National University of Singapore, Singapore)
Jiunn.H. Lin (Merck & Co., Inc., PA, USA)
Philip J. Lowe (Novartis Pharmaceuticals AG, Basel, Switzerland)
Takashi Mizuma (Tokyo University of Pharmacy and Life Sciences, Tokyo)
Teruo Murakami (Hiroshima International University, Hiroshima)
Kiyoshi Nagata (Tohoku Pharmaceutical University, Sendai)
Shinsaku Naito (Otsuka Pharmaceutical Factory, Inc., Tokushima)
Miki Nakajima (Kanazawa University, Kanazawa)
Takuo Ogihara (Takasaki University of Health and Welfare, Gunma)
Ronald S. Obach (Pfizer Inc., CT, USA)
Young-Ki Paik (Yonsei University, Korea)
Michael S. Roberts (University of Queensland, Australia)
Amin Rostami-Hodjegan (University of Sheffield, UK)
Chang-Koo Shim (Seoul National University, Korea)
Wichittra Tassaneeyakul (Khon Kaen University, Thailand)
Akira Yamamoto (Kyoto Pharmaceutical University, Kyoto)
Fumiyoshi Yamashita (Kyoto University, Kyoto)
Bingfang Yan (University of Rhode Island, RI, USA)
Masato Yasuhara (Tokyo Medical and Dental University, Tokyo)
Senior Advisor
Mitsuru Hashida (Kyoto University, Kyoto)
Masahiro Hayashi (Tokyo University of Pharmacy and Life Sciences, Tokyo)
Nick Holford (University of Auckland, New Zealand)
Ken-ichi Inui (Kyoto University Hospital, Kyoto)
William J. Jusko (State University of New York at Buffalo, NY, USA)
Tetsuya Kamataki (Tokyo Institute of Technology and Riken, Yokohama)
Akira Tsuji (Kanazawa University, Kanazawa)
Yasushi Yamazoe (Tohoku University, Sendai)
|
